PTK7 and familial pancreatic carcinoma: Prior research highlights its effectiveness in targeting PTK7,12 making it a promising tool for selectively targeting pancreatic cancer cells and tissues.13 Recent years have seen significant advances in drug delivery methods, particularly through the strategic use of nucleic acid aptamers.